CAR T-Cell Therapy for Relapsed/Refractory CLL
2 Visningar
• 07/14/23
0
0
Bädda in
administrator
Prenumeranter
The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna